NAV rose 2% to SEK 36.8 billion in Q2 2025, with strong operational performance from core companies and a robust net cash position of SEK 9.6 billion. Investments focused on healthcare and AI, while currency headwinds and U.S. policy changes present ongoing challenges.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.